Involvement of Th2 cytokines in the mouse model of flutamide-induced acute liver injury

Journal of Applied Toxicology

Volumn 32, Issue 10, 2012, Pages 815-822

  Higuchi, Satonori ^a   Kobayashi, Masanori ^a   Yano, Azusa ^a   Tsuneyama, Koichi ^b   Fukami, Tatsuki ^a   Nakajima, Miki ^a   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cytokines; DILI; IL 4; MIP 2; Prostaglandin D2

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN E2; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FLUTAMIDE; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 2; STAT6 PROTEIN; TRANSCRIPTION FACTOR GATA 3;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; LIVER INJURY; LIVER TOXICITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH2 CELL;

ANDROGEN ANTAGONISTS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTINEOPLASTIC AGENTS, HORMONAL; CYTOKINES; DRUG-INDUCED LIVER INJURY; FEMALE; FLUTAMIDE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; INTERLEUKIN-4; LIVER; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; PROSTAGLANDIN D2; RNA, MESSENGER; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS;

MUS;

EID: 84865817146     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1706     Document Type: Article

References (38)

1. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P, Guillouzo A. 1993. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. 44: 707-715.
2. Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, O'Shea JJ, Frucht DM. 2003. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J. Clin. Immunol. 23: 147-161.
3. Biedermann BT, Knelling M, Mailhammer R, Maier K, Sander CA, Kollias G, Kunkel S L, Hultner L, Rocken M. 2000. Mast cell control neutrophil recruitment during T cell-mediated delayed hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192: 1441-1451.
4. Coe KJ, Nelson SD, Ulrich RG, He Y, Dai X, Cheng O, Caguyoung M, Roberts CJ, Slatter JG. 2006. Profiling the hepatic effects of flutamide in rats: a microarray comparison with classical aryl hydrocarbon receptor ligands and atypical Cyp1a inducers. Drug Metab. Dispos. 34: 1266-1275; doi: 10.1124/dmd.105.009159.
5. Davies KJA. 1987. Protein damage and degradation by oxygen radicals. J. Biol. Chem. 262: 9895-9901.
6. Dourakis SP, Alexopoulou AA, Hadziyannis SJ. 1994. Fulminant hepatitis after flutamide treatment. J. Hepatol. 20: 350-353.
7. Fau D, Eugene D, Berson A, Letteron P, Fromenty B, Fisch C, Pessayre D. 1994. Toxicity of the antiandrogen flutamide in isolated rat hepatocytes. J. Pharmacol. Exp. Ther. 269: 954-962.
8. Gomez J, Dupont A, Cuan L, Tremblay M, Suburu R, Lemay M, Labrie, F. 1992. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am. J. Med. 92: 465-470.
9. Harada K, Water JV, Leung PSC, Coppel RL, Ansari A, Nakanuma Y, Gershwin ME. 1997. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 25: 791-796; doi: 10.1002/hep.510250402.
10. Hart W, Stricker BHC. 1989. Flutamide and hepatitis. Ann. Intern. Med. 110: 943-944.
11. Heneghan MA, McFarlane IG. 2002. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 35: 7-13; doi: 10.1053/jhep.2002.30991.
12. Higuchi S, Kobayashi M, Yoshikawa Y, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. 2011. IL-4 mediates dicloxacillin-induced liver injury in mice. Toxicol. Lett. 200: 139-145; doi: 10.1016/j.toxlet.2010.11.006.
13. Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG, Foster PS. 1998. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. 161: 1501-1509.
14. Holt MP, Ju C. 2006. Mechanisms of drug-induced liver injury. AAPS J. 8: E48-E54; doi: 10.1208/aapsj080106.
15. Jaeschke H, Hasegawa T. 2006. Role of neutrophils in acute inflammatory liver injury. Liver Int. 26: 912-919; doi: 10.1111/j.1478-3231.2006.01327.x.
16. Jaruga B, Hong F, Sun R, Radaeva S, Gao B. 2003. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukoctyes. J. Immunol. 171: 3233-3244.
17. Kashimshetty R, Desai VG, Kale VM, Lee T, Moland CL, Branham WS, New LS, Chan ECY, Younis H, Boelsterli UA. 2009. Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity. Toxicol. Appl. Pharmacol. 238: 150-159; doi: 10.1016/j.taap.2009.05.007.
18. Kay AB. 2001. Allergy and allergic diseases. New Engl. J. Med. 344: 30-37; doi: 10.1056/NEJM200101043440106.
19. Kidd P. 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8: 223-246.
20. Kita H, Macky IR, Van DWJ, Gershwin ME. 2001. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 120: 1485-1501.
21. Kobayashi E, Kobayashi M, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. 2009. Halothane-induced liver injury is mediated by interleukin-17 in mice. Toxicol. Sci. 111: 302-310; doi: 10.1093/toxsci/kfp165.
22. Kostenis E, Ulven T. 2006. Emerging roles of DP and CRTh2 in allergic inflammation. Trends Mol. Med. 12: 148-158; doi: 10.1016/j.molmed.2006.02.005.
23. Leonard WJ, O'Shea JJ. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16: 293-322; doi: 10.1146/annurev.immunol.16.1.293.
24. Matsuzaki Y, Nagai D, Ichimura E, Goda R, Tomura A, Doi M, Nishikawa K. 2006. Metabolism and hepatic toxicity of flutamide in cytochrome P450 1A2 knockout SV129 mice. J. Gastroenterol. 41: 231-239; doi: 10.1007/s00535-005-1749-y.
25. Moller S, Iversen P, Franzmann MB. 1990. Flutamide-induced liver failure. J. Hepatol. 10: 346-349.
26. Montgomery RA, Dallman MJ. 1991. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J. Immunol. 147: 554-560.
27. Morita M, Akai S, Hosomi H, Tsuneyama K, Nakajima M, Yokoi T. 2009. Drug-induced hepatotoxicity test using γ-glutamylcysteine synthetase knockdown rat. Toxicol. Lett. 189: 159-165; doi:10.1016/j.toxlet.2009.05.016.
28. Ohbuchi M, Miyata M, Nagai D, Shimada M, Yoshinari K, Yamazoe Y. 2009. Role of enzymatic N-hydroxylation and reduction in flutamide metabolite-induced liver toxicity. Drug Metab. Dispos. 37: 97-105; doi: 10.1124/dmd.108.021964.
29. Spanakis NE, Garinis GA, Alexopoulos EC, Patrinos GP, Menounos PG, Sklavounou A, Manolis NE, Gorgoulis VG, Valis D. 2002. Cytokines serum levels in patients with chronic HCV infection. J. Clin. Lab. Anal. 16: 40-46.
30. Spik I, Brenuchon C, Angeli V, Staumont D, Fleury S, Capron M, Trottein F, Dombrowicz D. 2005. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J. Immunol. 174: 3703-3708.
31. Srinivasan R, Buchweitz JP, Ganey PE. 1997. Alteration by flutamide of neutrophil response to stimulation. Implications for tissue injury. Biochem. Pharmacol. 53: 1179-1185.
32. Steinman L. 2007. A brief history of Th17, the first major revision in the Th1/Th2 hypothesis if T cell-mediated tissue damage. Nat. Rev. Med. 13: 139-145; doi: 10.1038/nm1551.
33. Takeshita K, Yamasaki T, Nagano K, Sugimoto H, Shichijo M, Gantner F, Bacon BK. 2004. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Int. Immunol. 16: 947-959; doi: 10.1093/intimm/dxh096.
34. Watanabe A, Fukami T, Nakajima M, Takamiya M, Aoki Y, Yokoi T. 2010. Human arylacetamide deacetylase is a principal enzyme in flutamide hydrosis. Drug Metab. Dispos. 37: 1513-1520; doi: 10.1124/dmd.110.033720.
35. Wysowski DK, Fourcroy JL. 1996. Flutamide hepatotoxicity. J. Urol. 155: 209-212.
36. Wysowski DK, Freiman JP, Tourtelot JB 1993. Fatal and nonfatal hepatotoxicity associated with flutamide. Ann. Intern. Med. 118: 860-864.
37. Yoshikawa Y, Morita M, Hosomi H, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. 2009a. Knockdown of superoxide disumutase 2 enhances acetaminophen-induced hepatotoxicity in rat. Toxicology 264: 89-95; doi: 10.1016/j.tox.2009.07.017.
38. Yoshikawa Y, Hosiomi H, Fukami T, Nakajima M, Yokoi T. 2009b. Establishment of knockdown of superoxide dismutase 2 and expression of CYP3A4 cell system to evaluate drug-induced cytotoxicity. Toxicol. in Vitro 23: 1179-1187; doi: 10.1016/j.tiv.2009.05.024.